Anesthetic management of morbidly obese patients

Seminars in Anesthesia Perioperative Medicine and Pain

Volumn 21, Issue 1, 2002, Pages 46-58

  Ogunnaike, Babautunde O ^a   Whitten, Charles W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ATRACURIUM; BENZODIAZEPINE DERIVATIVE; BROMIDE; CIMETIDINE; CITRIC ACID; DESFLURANE; FAMOTIDINE; FENFLURAMINE; HALOTHANE; HISTAMINE H2 RECEPTOR ANTAGONIST; LIDOCAINE; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; MUSCLE RELAXANT AGENT; OMEPRAZOLE; PROKINETIC AGENT; PROPOFOL; PROTON PUMP INHIBITOR; RANITIDINE; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VECURONIUM; VERAPAMIL;

ABSORPTION; ASPIRATION; HUMAN; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STOMACH PH;

EID: 0036489307     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sane.2002.30673     Document Type: Article

References (106)

1. Fisher A, Waterhouse TD, Adams AP: Obesity: Its relation to anaesthesia. Anaesthesia 30:633-647, 1975
2. National Institutes of Health Consensus Development Conference Statement: Health Implications of Obesity. Ann Int Med 103:147-151, 1985
3. Bray GA, Gray DS: Obesity: Part 1. Pathogenesis. West J Med 149:429-441, 1988
4. Peiris AN, Southmann MS, Hoffmann RG, et al: Adiposity, fat distribution and cardiovascular risk. Ann Int Med 110:867-872, 1989
5. Nakajima T, Fujioka S, Tokunaga K, et al: Correlation of intraabdominal fat accumulation and left ventricular function in obesity. Am J Cardiol 64:369-373, 1989
6. Adams JP, Murphy PG: Obesity in anaesthesia and intensive care. Br J Anaesth 85:91-108, 2000
7. McCarroll SM, Saunders PR, Bras PJ: Anesthetic considerations in obese patients. Progress in Anesthesiology 3:1-12, 1989
8. Stephenson J: First Federal Obesity Guidelines. JAMA 280:314, 1998 (letter)
9. Bray GA: Pathophysiology of obesity. Am J Clin Nutr 55:488-494, 1992 (suppl)
10. Luce JM: Respiratory complications of obesity. Chest 78:626-631, 1980
11. Øberg B, Poulsen TD: Obesity: An anaesthetic challenge. Acta Anaesthesiol Scand 40:191-200, 1996
12. Fritts HW, Filler J, Fishman AP, et al: The efficiency of ventilation during voluntary hyperpnea: studies in normal subjects and in dyspneic patients with either chronic pulmonary emphysema or obesity. J Clin Invest 38:1339-1348, 1959
13. Pelosi P, Croci M, Ravgnan I, et al: The effect of body mass on lung volume respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg 87:645-660, 1998
14. Hedenstierna, G, Santesson J, Norlander O: Airway closure and distribution of inspired gas in the extremely obese breathing spontaneously and during anaesthesia with intermittent positive pressure ventilation. Acta Anaesthesiol Scand 20:334-342, 1976
15. Andersen J, Rasmussen JP, Eriksen J: Pulmonary function in obese patients scheduled for jejuno-ileostomy. Acta Anaesthesiol Scand 21:346-351, 1977
16. Damia G, Mascheroni D, Croci M, et al: Perioperative changes in functional residual capacity in morbidly obese patients. Br J Anaesth 60:574-578, 1988
17. Halaka K, Mustajoki P, Aittomaki J, et al: Effect of weight loss and body position on pulmonary function and gas exchange abnormalities in morbid obesity. Int J Obes Relat Metab Disord 19:343-346, 1985
18. Hunter JD, Reid C, Noble D: Anaesthetic management of the morbidly obese patient. Hosp Med 59:481-483, 1998
19. Gajraj NM, Whitten CW: Morbid Obesity, in Atlee JL (ed). Complications in Anesthesia. Philadelphia, PA, Saunders, 1999, pp 848-850
20. Murphy PG: Obesity, in Hemmings JC Jr, Hopkins PM (eds.) Foundations of Anaesthesia. Basic and Clinical Sciences. London, Mosby, 2000, pp 703-711
21. Brodsky JB: Anesthetic management of the morbidly obese patient. Int Anesthesiol Clin 24:93-103, 1986
22. Alexander JK: Obesity and cardiac performance. Am J Cardiol 14:860-865, 1964
23. Bjerkedal T: Overweight and hypertension. Acta Med Scand 159:13-26, 1957
24. Mann GV: The influence of obesity on health. N Eng J Med 291:178-185, 1974
25. Messerli FH: Cardiovascular effects of obesity and hypertension. Lancet 1:1165-1168, 1982
26. Backman L, Freyschuss V, Hallberg D, et al: Cardiovascular function in extreme obesity. Acta Med Scand 193:437-446, 1973
27. Alexander JK, Dennis EW, Smith WG, et al: Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovascular Res Center Bull 1:39-44, 1962
28. Alpert MA, Hashimi MW: Obesity and the heart. Am J Med Sci 306:117-123, 1993
29. Alpert MA, Lambert CR, Terry BE, et al: Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 130:1068-1073, 1995
30. Manson JE, Colditz FA, Stampfer MJ, et al: A prospective study of obesity and risk of coronary heart disease in women. New Engl J Med 322:882-889, 1990
31. Shenkman Z, Shir Y, Brodsky JB: Perioperative management of the obese patient. Br J Anaesth 70:349-359, 1993
32. Buckley FP: Anesthetizing the morbidly obese patient. ASA Refresher Courses 243:1-6, 1989
33. Vaughan RW, Bauer S, Wise L: Volume and pH of gastric juice in obese patients. Anesthesiology 43:686-689, 1975
34. Wisen O, Hellstrom PM: Gastrointestinal motility in obesity. J Int Med 273:411-418, 1995
35. Tosetti C, Corinaldesi R, Stranghellini V, et al: Gastric emptying of solids in morbid obesity. Int J Obes Relat Metab Disord 20:200-205, 1996
36. Nishina K, Mikawa K, Maekawa N, et al: Omeprazole reduces preoperative gastric fluid acidity and volume in children. Can J Anaesth 41:925-929, 1994
37. Vaughan RW: Biochemical and biotransformation alterations in obesity, in Brown Jr (ed). Contemporary Anesthesia Practice Series. Philadelphia, PA, FA Davis, 1982, pp 55-70
38. Nomura F, Ohnishi K, Satomura Y, et al: Liver function in moderate obesity: study in 536 moderately obese subjects among 4613 male company employees. Int J Obes 10:349-354, 1986
39. Manchikanti L, Roush JR, Colliver JA, et al: Effect of preanesthetic ranitidine and metoclopramide on gastric contests in morbidly obese patients. Anesth Analg 65:195-199, 1986
40. Vaughan RW, Conahan TJ: Cardiopulmonary consequences of morbid obesity. Life Sci 26:2119-2127, 1980
41. Buckley PF: Anesthesia and obesity and gastrointestinal disorders, in Barash PG, Cullen BF, Stoelting RK (eds). Clinical Anesthesia. Phildelphia, PA, Lippincott-Raven, 1996, pp 975-989
42. Raucoles-Aime M, Brimaud D: Diabetes mellitus: Implications for the anesthesiologist. Curr Opin Anesth 9:247-251, 1996
43. Barzelai N: Obesity: Age-associated weight gain and the development of disease. Geriatrics 54:57-64, 1999
44. Erlinger TP, Pollack H, Appel LJ: Nutrition-related cardiovascular risk factor in older people: Results from the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 48:1486-1489, 2000
45. Larson B: Regional obesity as a health hazard in men - Prospectives studies. Acta Med Scand 723:45-51, 1992 (suppl)
46. Abernethy DR, Greenblatt DJ: Drug disposition in obese humans: An update. Clin Pharmacokinet 11:199-213, 1986
47. Blouin RA, Kolpek JH, Mann HJ: Influence of obesity on drug disposition. Clin Pharm 6:706-714, 1987
48. Abernethy DR, Greenblatt DJ: Pharmacokinetics of drugs in obesity. Clin Pharacokinet 7:108-124, 1982
49. Cheymol G: Clinical pharmacokinetics of drugs in obesity: An update. Clin Pharmacokinet 25:103-114, 1993
50. Marik P, Varon J: The obese patient in the ICU. Chest 113:492-498, 1998
51. Bentley JB, Vaughan RW, Miller MS, et al: Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia. Anesth Analg 58:409-412, 1979
52. Bentley JB, Vaughan RW, Gandolfi AJ, et al: Halothane biotransformation in obese and non-obese patients. Anesthesiology 57:94-97, 1982
53. Higuchi H, Satoh T, Arimura S, et al: Serum inorganic fluoride levels in mildly obese patients during and after sevoflurane anesthesia. Anesth Analg 77:1018-1021, 1993
54. Frink EJ, Malan TP, Brown EA, et al: Plasma inorganic fluoride levels with sevoflurane anesthesia in morbidly obese and non-obese patients. Anesth Analg 76:1333-1337, 1993
55. Strube PJ, Hulands GH, Halsey MJ: Serum fluoride levels in morbidly obese patients: Enflurane compared with isoflurane anaesthesia. Anaesthesia 42:685-689, 1987
56. Juvin P, Vadam C, Malek L, et al: Postoperative recovery after desflurane, propofol or isoflurane anesthesia among morbidly obese patients: A prospective, randomized study. Anesth Analg 91:714-719, 2000
57. Jung D, Mayersohn M, Perrier D, et al: Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 56:269-274, 1982
58. Sevin F, Farinotti R, Haberer JP, et al: Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 78:657-665, 1993
59. Greenblatt DJ, Abernethy DR, Locniskar A, et al: Effect of age, gender and obesity on midazolam kinetics. Anesthesiology 61:27-35, 1984
60. Bently JB, Borel JD, Vaughan RW, et al: Weight, pseudocholinesterase activity and succinylcholine requirement. Anesthesiology 57:48-49, 1982
61. Tsueda K, Warren JE, McCafferty LA, et al: Pancuronium bromide requirement during anesthesia for the morbidly obese. Anesthesiology 48:438-439, 1978
62. Schwartz AE, Matteo RS, Ornstein E, et al: Pharmacokinetics and dynamics of metocurine in the obese. Anesthesiology 65:295, 1986 (abstr)
63. Weinstein JA, Matteo RS, Ornstein E, et al: Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 67:1149-1153, 1988
64. Puhringer FK, Keller C, Kleinsasser A, et al: Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 16:507-510, 1999
65. Puhringer FK, Khuenl-Brady KS, Mitterschiffthaler G: Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients. Eur J Anaesthesiol Suppl 11:107-110, 1995
66. Bently JB, Borel JD, Gillespie TJ, et al: Fentanyl pharmacokinetics in obese and nonobese patients. Anesthesiology 55:177, 1981 (abstr)
67. Bentley JB, Finley JM, Humphrey LR, et al: Obesity and alfentanil pharmacokinetics. Anesth Analg 62:251, 1983 (abstr)
68. Schwartz AE, Matteo RS, Ornstein E, et al: Pharmacokinetics of sufentanil in obese patients. Anesth Analg 73:790-793, 1991
69. Egan TD, Huizinga B, Gupta SK, et al: Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 89:562-573, 1998
70. Song D, Whitten CW, White PF: Remifentanil infusion facilitates early recovery for obese outpatients undergoing laparoscopic cholecystectomy. Anesth Analg 90:1111-1113, 2000
71. Jeffers LA: Anesthetic considerations for the new anti-obesity medications. AANA J 64:541-544, 1996
72. Silverstone T: Appetite suppressants. A review. Drugs 43:820-836, 1992
73. Horowitz M, Collins PJ, Tuckwell V, et al: Fenfluramine delays gastric emptying of solid food. Br J Clin Pharmacol 19:849-851, 1985
74. Pindar RM, Brogden RN, Sawyer PR, et al: Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10:241-323, 1975
75. Pouwels HM, Smeets JL, Cheriex EC, et al: Pulmonary hypertension and fenfluramine. Eur Respir J 3:606-607, 1990
76. McMurray J, Bloomfield P, Miller HC: Irreversible pulmonary hypertension after treatment with fenfluramine. Br Med J 292:239-240, 1986
77. Lee JT, Larson RH, Buckley JJ, et al: Airway maintenance in the morbidly obese. Anesth Rev 7:33-36, 1980
78. Wilson SL: Effects of atropine, glucopyrrolate and cimetidine on gastric secretions in morbidly obese patients. Anesth Analg 60:37-40, 1981
79. Talke PO, Solanki DR: Dose-response study of oral famotidine for reduction of gastric acidity and volume in outpatients and inpatients. Anesth Analg 77:1143-1148, 1993
80. Kakkar VV, Howe CT, Nicolaides AN, et al: Deep vein thrombosis of the leg: Is there a "high risk" group? Ann Surg 120:527-532, 1970
81. Cooper JR, Brodsky JB: Anesthetic management of the morbidly obese patient. Seminars in Anesthesia 6:260-270, 1987
82. Jupiter JB, Ring D, Rosen H: The complications and difficulties of management of non union in the severely obese. J Ortopaed Trauma 9:363-370, 1995
83. Brodsky JB, Wyner T, Ehrenwerth J, et al: One lung anesthesia in morbidly obese patients. Anesthesiology 57:132-134, 1982
84. Paul DR, Hoyt JL, Boutros RR: Cardiovascular and respiratory changes in response to changes in posture in the very obese. Anesthesiology 45:73-77, 1976
85. Hill SA: Anaesthetic dilemmas: Obese patient with coexisting anesthetic problems. Br J Hosp Med 50:205, 1993
86. Wallace DH, Currie JM, Gilstrap LC, et al: Indirect sonographic guidance for epidural anesthesia in obese pregnant patients. Reg Anesth 17:233-236, 1992
87. Dumont L, Mattys M, Mardirosoff C, et al: Changes on pulmonary mechanics during laparoscopic gastroplasty in morbidly obese patients. Acta Anaesthesiol Scand 41:408-413, 1997
88. Pitkanen MT: Body mass and spread of spinal anesthesia with bupivacaine. Anesth Analg 66:127-131, 1987
89. 4-5 interspace. Br J Anaesth 64:542-546, 1990
90. Wilson AT, Reilly CS: Anaesthesia and the obese patient. Int J Obes 17:427-435, 1993
91. Buckley FP, Robinson NB, Sumonowitz DA: Anaesthesia in the morbidly obese. A comparison of anaesthetic and analgesic regimens for upper abdominal surgery. Anaesthesia 38:840-851, 1983
92. Fox GS, Whalley DG, Bevan OR: Anaesthesia for the morbidly obese: Experience with 110 patients. Br J Anaesth 53:811-816, 1981
93. Vaughan RW: Anesthetic management of the morbidly obese patient, in Brown BR, Blitt CD, Giesecke AH, Vaughan RW (eds). Anesthesia and the obese patient. New York, NY, Davis Company, 1982, pp 71-94
94. Goldberg ME, Norris MC, Larijani GE, et al: Preoxygenation in the morbidly obese: A comparison of two techniques. Anesth Analg 68:520-522, 1989
95. Kirby IJ, Howard EC: Propofol in a morbidly obese patient. Anaesthesia 42:1125-1126, 1987
96. Buckley FP: Anaesthesia for the morbidly obese patient. Can J Anaesth 41:R94-R100, 1994
97. Fox GS: Anaesthesia for intestinal short circuiting in the morbidly obese with reference to the pathophysiology of gross obesity. Can Anaesth Soc J 22:307-315, 1975
98. Robertson IK, Eltringham RJ: Anaesthetic management of the morbidly obese. Br J Hosp Med 42:224-228, 1985
99. Salem MR, Dalal FY, Zygmunt MP, et al: Does PEEP improve intraoperative arterial oxygenation in grossly obese patients? Anesthesiology 48:280-281, 1978
100. Vaughan RW, Bauer S, Wise L: Effect of position (semirecumbent versus supine) on postoperative oxygenation in markedly obese subjects. Anesth Analg 55:37-41, 1976
101. Söderberg M, Thomson D, White T: Respiration, circulation and anaesthetic management in obesity. Investigation before and after jejunoileal bypass. Acta Anaesthesiol Scand 21:55-61, 1977
102. Joris J, Sottiaux T, Chiche JD, et al: Bi-level CPAP (BIPAP) reduces the postoperative restrictive pulmonary syndrome in obese patients after gastroplasty. Br J Anaesth 72:111, 1994 (suppl, abstr)
103. Rawal N, Sjöstrand U, Christofferson E, et al: Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese. Influence on postoperative ambulation and pulmonary function. Anesth Analg 63:583-592, 1984
104. Gelman S, Laws HL, Potzick J, et al: Thoracic epidural vs. balanced anesthesia in morbid obesity: An intraoperative and postoperative hemodynamic study. Anesth Analg 59:902-908, 1980
105. Bennett R, Batenhorst R, Graves DA, et al: Variation in postoperative analgesic requirements in the morbidly obese following gastric bypass surgery. Pharmacotherapy 2:50-53, 1982
106. Van Dercar DH, Martinez AP, De Lisser EA: Sleep apnea syndromes: a potential contraindication for patient-controlled analgesia. Anesthesiology 74:623-624, 1991